Why is Novartis India falling/rising?

As of 11-Jul, Novartis India Ltd is currently priced at 1,066.50, reflecting a decrease of 5.5 points or 0.51%. Despite this decline, the stock has shown positive performance over the past week and month, with returns of 2.34% and 4.89%, respectively. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally upward trend in the longer term. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 246.72% against the 5-day average. The company has a low debt-to-equity ratio and has demonstrated strong long-term growth, with operating profit increasing at an annual rate of 141.64%. Recent positive financial results, including substantial growth in profit before tax and profit after tax, further support the stock's potential.
In the broader market context, Novartis India has outperformed the Sensex over the past week and month, while the benchmark has experienced a decline of 1.12% and a flat return of -0.02%, respectively. However, the stock has underperformed its sector today by 1.09%. Over the year, Novartis India has seen a decline of 8.16%, contrasting with the Sensex's gain of 3.26%, indicating that while the stock has had strong short-term performance, it has struggled in the longer term compared to the broader market. This mixed performance suggests that while there are positive indicators for Novartis India, the recent price drop may reflect broader market pressures or sector-specific challenges.